Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/26/25 18:32 | 9/25/25 | RXRX | Health | BioPrd | Biological Products, (No Diag | Gibson Christopher | UT | DO | CEO | 15 | S.dm | -9,431 | 5.94 | 0 | -1,587 | 1,273 | D | |||||||||||||||
8/19/25 18:22 | 8/18/25 | RXRX | Health | BioPrd | Biological Products, (No Diag | Khan Najat | UT | DO | Chief R, | 1 | S | -202 | 5.52 | 0 | -37 | 668 | D | |||||||||||||||
11/14/24 19:19 | 11/12/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Borgeson Blake | UT | D | 13 | S | -1,113 | 7.48 | 0 | -149 | 7,189 | D | ||||||||||||||||
11/14/24 19:19 | 11/12/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Secora Michael | UT | O | CFO | 6 | S.dm | -1,295 | 7.19 | 0 | -180 | 1,500 | D | |||||||||||||||
10/28/24 17:25 | 10/24/24 | RXRX | Health | BioPrd | Biological Products, (No Diag | Marriott Tina | UT | O | P,COO | 6 | S.d | -244 | 7.38 | 0 | -33 | 535 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |